Use of IMGT® Databases and Tools for Antibody Engineering and Humanization

IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMG...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antibody Engineering 2018, Vol.1827, p.35-69
Hauptverfasser: Lefranc, Marie-Paule, Ehrenmann, François, Kossida, Sofia, Giudicelli, Véronique, Duroux, Patrice
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 69
container_issue
container_start_page 35
container_title Antibody Engineering
container_volume 1827
creator Lefranc, Marie-Paule
Ehrenmann, François
Kossida, Sofia
Giudicelli, Véronique
Duroux, Patrice
description IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. Standardized sequence and structure analysis of antibody using IMGT® databases and tools allow one to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on the IMGT-ONTOLOGY concepts of classification (IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT Collier de Perles). IMGT® is acknowledged as the global reference for immunogenetics and immunoinformatics, and its standards are particularly useful for antibody engineering and humanization. IMGT® databases for antibody nucleotide sequences and genes include IMGT/LIGM-DB and IMGT/GENE-DB, respectively, and nucleotide sequence analysis is performed by the IMGT/V-QUEST and IMGT/JunctionAnalysis tools and for NGS by IMGT/HighV-QUEST. In this chapter, we focus on IMGT® databases and tools for amino acid sequences, two-dimensional (2D) and three-dimensional (3D) structures: the IMGT/DomainGapAlign and IMGT Collier de Perles tools and the IMGT/2Dstructure-DB and IMGT/3Dstructure-DB database. IMGT/mAb-DB provides the query interface for monoclonal antibodies (mAb), fusion proteins for immune applications (FPIA), and composite proteins for clinical applications (CPCA) and related proteins of interest (RPI) and links to the proposed and recommended lists of the World Health Organization International Nonproprietary Name (WHO INN) programme, to IMGT/2Dstructure-DB for amino acid sequences, and to IMGT/3Dstructure-DB and its associated tools (IMGT/StructuralQuery, IMGT/DomainSuperimpose) for crystallized antibodies.
doi_str_mv 10.1007/978-1-4939-8648-4_3
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04237636v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2101919140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2893-7c00f8af9f06fd6b61863d5797fdf44082016cf626ce20aeaebe143594e624c43</originalsourceid><addsrcrecordid>eNpVkc9OGzEQh90_qCCaJ0Cq9kgPhhl7Yq-PEVCCCOolnC3vrg0Lm3W6TpDoQ_Uh-mR4CVSq5jDSbz6NNPMxdoRwggD61OiSIycjDS8VlZys_MAmOcUxGyP6yA7QEHAFwnz6b6b15zwDRVxqmu6zSUoPACAQp4TmC9uXgEaRwQN2fZt8EUNxdXO5_PunOHcbV7nkU-H6pljG2KUixKGY9Zu2is1zcdHftb33Q9vfvSLz7cr17W-3aWP_le0F1yU_eeuH7PbHxfJszhc_L6_OZgtei9JIrmuAULpgAqjQqEphqWQz1UaHJhBBKQBVHZRQtRfgvPOVR5JTQ14Jqkkesu-7vfeus-uhXbnh2UbX2vlsYccMSEitpHrCzB7v2PUQf2192thVm2rfda73cZuswPyKXAQZ_faGbquVb_5tfn9WBnAHpPV4vx9sFeNjsgh2dGazAYt2dGBHQTY7ky-E13-3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2101919140</pqid></control><display><type>article</type><title>Use of IMGT® Databases and Tools for Antibody Engineering and Humanization</title><source>Springer Books</source><creator>Lefranc, Marie-Paule ; Ehrenmann, François ; Kossida, Sofia ; Giudicelli, Véronique ; Duroux, Patrice</creator><contributor>Chames, Patrick ; Nevoltris, Damien</contributor><creatorcontrib>Lefranc, Marie-Paule ; Ehrenmann, François ; Kossida, Sofia ; Giudicelli, Véronique ; Duroux, Patrice ; Chames, Patrick ; Nevoltris, Damien</creatorcontrib><description>IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. Standardized sequence and structure analysis of antibody using IMGT® databases and tools allow one to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on the IMGT-ONTOLOGY concepts of classification (IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT Collier de Perles). IMGT® is acknowledged as the global reference for immunogenetics and immunoinformatics, and its standards are particularly useful for antibody engineering and humanization. IMGT® databases for antibody nucleotide sequences and genes include IMGT/LIGM-DB and IMGT/GENE-DB, respectively, and nucleotide sequence analysis is performed by the IMGT/V-QUEST and IMGT/JunctionAnalysis tools and for NGS by IMGT/HighV-QUEST. In this chapter, we focus on IMGT® databases and tools for amino acid sequences, two-dimensional (2D) and three-dimensional (3D) structures: the IMGT/DomainGapAlign and IMGT Collier de Perles tools and the IMGT/2Dstructure-DB and IMGT/3Dstructure-DB database. IMGT/mAb-DB provides the query interface for monoclonal antibodies (mAb), fusion proteins for immune applications (FPIA), and composite proteins for clinical applications (CPCA) and related proteins of interest (RPI) and links to the proposed and recommended lists of the World Health Organization International Nonproprietary Name (WHO INN) programme, to IMGT/2Dstructure-DB for amino acid sequences, and to IMGT/3Dstructure-DB and its associated tools (IMGT/StructuralQuery, IMGT/DomainSuperimpose) for crystallized antibodies.</description><identifier>ISSN: 1064-3745</identifier><identifier>ISBN: 9781493986477</identifier><identifier>ISBN: 1493986473</identifier><identifier>EISSN: 1940-6029</identifier><identifier>EISBN: 9781493986484</identifier><identifier>EISBN: 1493986481</identifier><identifier>DOI: 10.1007/978-1-4939-8648-4_3</identifier><identifier>PMID: 30196491</identifier><language>eng</language><publisher>New York, NY: Springer New York</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies, Monoclonal, Humanized ; Antibody humanization ; B cell epitope ; Biochemistry, Molecular Biology ; C domain ; Databases, Protein ; Epitopes ; Humans ; IMGT ; IMGT Collier de Perles ; IMGT unique numbering ; IMGT-ONTOLOGY ; Immunogenetics ; Immunoglobulin ; Life Sciences ; Mice ; Paratope ; Protein Domains ; Protein Engineering ; V domain</subject><ispartof>Antibody Engineering, 2018, Vol.1827, p.35-69</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2018</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2893-7c00f8af9f06fd6b61863d5797fdf44082016cf626ce20aeaebe143594e624c43</citedby><orcidid>0000-0003-0116-9353 ; 0000-0001-8935-7900 ; 0000-0003-2727-0070 ; 0000-0003-2482-0022 ; 0000-0002-2258-468X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/978-1-4939-8648-4_3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/978-1-4939-8648-4_3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,779,780,784,793,885,27923,38253,41440,42509</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30196491$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04237636$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Chames, Patrick</contributor><contributor>Nevoltris, Damien</contributor><creatorcontrib>Lefranc, Marie-Paule</creatorcontrib><creatorcontrib>Ehrenmann, François</creatorcontrib><creatorcontrib>Kossida, Sofia</creatorcontrib><creatorcontrib>Giudicelli, Véronique</creatorcontrib><creatorcontrib>Duroux, Patrice</creatorcontrib><title>Use of IMGT® Databases and Tools for Antibody Engineering and Humanization</title><title>Antibody Engineering</title><addtitle>Methods Mol Biol</addtitle><description>IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. Standardized sequence and structure analysis of antibody using IMGT® databases and tools allow one to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on the IMGT-ONTOLOGY concepts of classification (IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT Collier de Perles). IMGT® is acknowledged as the global reference for immunogenetics and immunoinformatics, and its standards are particularly useful for antibody engineering and humanization. IMGT® databases for antibody nucleotide sequences and genes include IMGT/LIGM-DB and IMGT/GENE-DB, respectively, and nucleotide sequence analysis is performed by the IMGT/V-QUEST and IMGT/JunctionAnalysis tools and for NGS by IMGT/HighV-QUEST. In this chapter, we focus on IMGT® databases and tools for amino acid sequences, two-dimensional (2D) and three-dimensional (3D) structures: the IMGT/DomainGapAlign and IMGT Collier de Perles tools and the IMGT/2Dstructure-DB and IMGT/3Dstructure-DB database. IMGT/mAb-DB provides the query interface for monoclonal antibodies (mAb), fusion proteins for immune applications (FPIA), and composite proteins for clinical applications (CPCA) and related proteins of interest (RPI) and links to the proposed and recommended lists of the World Health Organization International Nonproprietary Name (WHO INN) programme, to IMGT/2Dstructure-DB for amino acid sequences, and to IMGT/3Dstructure-DB and its associated tools (IMGT/StructuralQuery, IMGT/DomainSuperimpose) for crystallized antibodies.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Antibody humanization</subject><subject>B cell epitope</subject><subject>Biochemistry, Molecular Biology</subject><subject>C domain</subject><subject>Databases, Protein</subject><subject>Epitopes</subject><subject>Humans</subject><subject>IMGT</subject><subject>IMGT Collier de Perles</subject><subject>IMGT unique numbering</subject><subject>IMGT-ONTOLOGY</subject><subject>Immunogenetics</subject><subject>Immunoglobulin</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Paratope</subject><subject>Protein Domains</subject><subject>Protein Engineering</subject><subject>V domain</subject><issn>1064-3745</issn><issn>1940-6029</issn><isbn>9781493986477</isbn><isbn>1493986473</isbn><isbn>9781493986484</isbn><isbn>1493986481</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkc9OGzEQh90_qCCaJ0Cq9kgPhhl7Yq-PEVCCCOolnC3vrg0Lm3W6TpDoQ_Uh-mR4CVSq5jDSbz6NNPMxdoRwggD61OiSIycjDS8VlZys_MAmOcUxGyP6yA7QEHAFwnz6b6b15zwDRVxqmu6zSUoPACAQp4TmC9uXgEaRwQN2fZt8EUNxdXO5_PunOHcbV7nkU-H6pljG2KUixKGY9Zu2is1zcdHftb33Q9vfvSLz7cr17W-3aWP_le0F1yU_eeuH7PbHxfJszhc_L6_OZgtei9JIrmuAULpgAqjQqEphqWQz1UaHJhBBKQBVHZRQtRfgvPOVR5JTQ14Jqkkesu-7vfeus-uhXbnh2UbX2vlsYccMSEitpHrCzB7v2PUQf2192thVm2rfda73cZuswPyKXAQZ_faGbquVb_5tfn9WBnAHpPV4vx9sFeNjsgh2dGazAYt2dGBHQTY7ky-E13-3</recordid><startdate>2018</startdate><enddate>2018</enddate><creator>Lefranc, Marie-Paule</creator><creator>Ehrenmann, François</creator><creator>Kossida, Sofia</creator><creator>Giudicelli, Véronique</creator><creator>Duroux, Patrice</creator><general>Springer New York</general><scope>NPM</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-0116-9353</orcidid><orcidid>https://orcid.org/0000-0001-8935-7900</orcidid><orcidid>https://orcid.org/0000-0003-2727-0070</orcidid><orcidid>https://orcid.org/0000-0003-2482-0022</orcidid><orcidid>https://orcid.org/0000-0002-2258-468X</orcidid></search><sort><creationdate>2018</creationdate><title>Use of IMGT® Databases and Tools for Antibody Engineering and Humanization</title><author>Lefranc, Marie-Paule ; Ehrenmann, François ; Kossida, Sofia ; Giudicelli, Véronique ; Duroux, Patrice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2893-7c00f8af9f06fd6b61863d5797fdf44082016cf626ce20aeaebe143594e624c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Antibody humanization</topic><topic>B cell epitope</topic><topic>Biochemistry, Molecular Biology</topic><topic>C domain</topic><topic>Databases, Protein</topic><topic>Epitopes</topic><topic>Humans</topic><topic>IMGT</topic><topic>IMGT Collier de Perles</topic><topic>IMGT unique numbering</topic><topic>IMGT-ONTOLOGY</topic><topic>Immunogenetics</topic><topic>Immunoglobulin</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Paratope</topic><topic>Protein Domains</topic><topic>Protein Engineering</topic><topic>V domain</topic><toplevel>online_resources</toplevel><creatorcontrib>Lefranc, Marie-Paule</creatorcontrib><creatorcontrib>Ehrenmann, François</creatorcontrib><creatorcontrib>Kossida, Sofia</creatorcontrib><creatorcontrib>Giudicelli, Véronique</creatorcontrib><creatorcontrib>Duroux, Patrice</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Antibody Engineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lefranc, Marie-Paule</au><au>Ehrenmann, François</au><au>Kossida, Sofia</au><au>Giudicelli, Véronique</au><au>Duroux, Patrice</au><au>Chames, Patrick</au><au>Nevoltris, Damien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of IMGT® Databases and Tools for Antibody Engineering and Humanization</atitle><jtitle>Antibody Engineering</jtitle><addtitle>Methods Mol Biol</addtitle><date>2018</date><risdate>2018</risdate><volume>1827</volume><spage>35</spage><epage>69</epage><pages>35-69</pages><issn>1064-3745</issn><eissn>1940-6029</eissn><isbn>9781493986477</isbn><isbn>1493986473</isbn><eisbn>9781493986484</eisbn><eisbn>1493986481</eisbn><abstract>IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. Standardized sequence and structure analysis of antibody using IMGT® databases and tools allow one to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on the IMGT-ONTOLOGY concepts of classification (IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT Collier de Perles). IMGT® is acknowledged as the global reference for immunogenetics and immunoinformatics, and its standards are particularly useful for antibody engineering and humanization. IMGT® databases for antibody nucleotide sequences and genes include IMGT/LIGM-DB and IMGT/GENE-DB, respectively, and nucleotide sequence analysis is performed by the IMGT/V-QUEST and IMGT/JunctionAnalysis tools and for NGS by IMGT/HighV-QUEST. In this chapter, we focus on IMGT® databases and tools for amino acid sequences, two-dimensional (2D) and three-dimensional (3D) structures: the IMGT/DomainGapAlign and IMGT Collier de Perles tools and the IMGT/2Dstructure-DB and IMGT/3Dstructure-DB database. IMGT/mAb-DB provides the query interface for monoclonal antibodies (mAb), fusion proteins for immune applications (FPIA), and composite proteins for clinical applications (CPCA) and related proteins of interest (RPI) and links to the proposed and recommended lists of the World Health Organization International Nonproprietary Name (WHO INN) programme, to IMGT/2Dstructure-DB for amino acid sequences, and to IMGT/3Dstructure-DB and its associated tools (IMGT/StructuralQuery, IMGT/DomainSuperimpose) for crystallized antibodies.</abstract><cop>New York, NY</cop><pub>Springer New York</pub><pmid>30196491</pmid><doi>10.1007/978-1-4939-8648-4_3</doi><tpages>35</tpages><orcidid>https://orcid.org/0000-0003-0116-9353</orcidid><orcidid>https://orcid.org/0000-0001-8935-7900</orcidid><orcidid>https://orcid.org/0000-0003-2727-0070</orcidid><orcidid>https://orcid.org/0000-0003-2482-0022</orcidid><orcidid>https://orcid.org/0000-0002-2258-468X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1064-3745
ispartof Antibody Engineering, 2018, Vol.1827, p.35-69
issn 1064-3745
1940-6029
language eng
recordid cdi_hal_primary_oai_HAL_hal_04237636v1
source Springer Books
subjects Amino Acid Sequence
Animals
Antibodies, Monoclonal, Humanized
Antibody humanization
B cell epitope
Biochemistry, Molecular Biology
C domain
Databases, Protein
Epitopes
Humans
IMGT
IMGT Collier de Perles
IMGT unique numbering
IMGT-ONTOLOGY
Immunogenetics
Immunoglobulin
Life Sciences
Mice
Paratope
Protein Domains
Protein Engineering
V domain
title Use of IMGT® Databases and Tools for Antibody Engineering and Humanization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T00%3A20%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20IMGT%C2%AE%20Databases%20and%20Tools%20for%20Antibody%20Engineering%20and%20Humanization&rft.jtitle=Antibody%20Engineering&rft.au=Lefranc,%20Marie-Paule&rft.date=2018&rft.volume=1827&rft.spage=35&rft.epage=69&rft.pages=35-69&rft.issn=1064-3745&rft.eissn=1940-6029&rft.isbn=9781493986477&rft.isbn_list=1493986473&rft_id=info:doi/10.1007/978-1-4939-8648-4_3&rft_dat=%3Cproquest_hal_p%3E2101919140%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&rft.eisbn=9781493986484&rft.eisbn_list=1493986481&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2101919140&rft_id=info:pmid/30196491&rfr_iscdi=true